Purpose Assessing the risk of common, complex diseases requires consideration of clinical
risk factors as well as monogenic and polygenic risks, which in turn may be reflected in …

The advancement of precision medicine requires new methods to coordinate and deliver
genetic data from heterogeneous sources to physicians and patients. The eMERGE III Network …

A goal of the 3rd phase of the Electronic Medical Records and Genomics (eMERGE3) Network
was to examine the return of results (RoR) of actionable variants in more than 100 genes …

Purpose Secondary findings are typically offered in an all or none fashion when sequencing
is used for clinical purposes. This study aims to describe the process of offering categorical …

The public health impact of genomic screening can be enhanced by cascade testing.
However, cascade testing depends on communication of results to family members. While the …

Purpose The goal of Electronic Medical Records and Genomics (eMERGE) Phase III Network
was to return actionable sequence variants to 25,084 consenting participants from 10 …

Background Unbiased estimates of penetrance are challenging but critically important to
make informed choices about strategies for risk management through increased surveillance …

Background Noninvasive prenatal screening has become an increasingly prevalent choice
for women who desire aneuploidy screening. Although the test characteristics are impressive…

Increasing interest and pursuit of genetic testing by the general public have raised concerns
about their understanding and use of their results. While most research has focused on …

Prior research has demonstrated that genomic medicine has promise for improving health
outcomes. As a result, it is beginning to emerge into the clinical practice for selected …